BidSi6 and BidEL isoforms as a potential marker for predicting colorectal adenomatous polyps

Area of Science:

• Molecular Biology
• Cancer Research
• Biomarker Discovery

Background:

• The Bid gene links extrinsic and intrinsic apoptotic pathways, crucial for cell proliferation.
• Bid protein isoforms, BidSi6 and BidEL, are investigated for their role in colorectal cancer development.

Purpose of the Study:

• To evaluate BidSi6 and BidEL expression in colorectal adenomatous polyps as potential biomarkers.
• To investigate the relationship between Bid isoform expression and clinicopathological factors.

Main Methods:

• Quantitative Real-Time PCR (qReal-Time PCR) was used to measure BidSi6 and BidEL expression.
• Expression levels were compared between adenomatous polyps, adjacent non-polyp tissues, and normal colon tissues.
• Receiver Operating Characteristic (ROC) curve analysis assessed diagnostic capacity, and sequencing identified the BidSi6 isoform.

Main Results:

• BidSi6 and BidEL isoforms were significantly overexpressed in adenomatous polyps and adjacent non-polyp tissues compared to normal colon tissues.
• No significant difference in expression was found between polyps and adjacent non-polyp tissues.
• ROC analysis indicated a powerful diagnostic capability for both BidSi6 and BidEL isoforms.

Conclusions:

• BidSi6 and BidEL isoforms show potential as novel biomarkers for adenomatous polyps.
• The findings support the use of these isoforms in the early detection and diagnosis of colorectal polyps.